DCF — CLEVELAND CLINIC HOSPITAL
Enterprise Value: $-16.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.9B
Enterprise Value
$-5.2B
PV of Cash Flows
$-11.7B
PV of Terminal Value
$-18.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $6.6B | $-1.1B | -17.0% | $-1.4B | $-1.3B |
| Year 2 | $6.8B | $-1.1B | -16.0% | $-1.4B | $-1.1B |
| Year 3 | $7.0B | $-1.1B | -15.0% | $-1.4B | $-1.0B |
| Year 4 | $7.2B | $-1.1B | -15.0% | $-1.4B | $-928.1M |
| Year 5 | $7.4B | $-1.1B | -14.0% | $-1.4B | $-857.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$6.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17693704775299152
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5